Literature DB >> 10392749

Developmental patterns and neuropsychological assessment in patients with carbohydrate-deficient glycoconjugate syndrome type IA (phosphomannomutase deficiency).

R Barone1, L Pavone, A Fiumara, R Bianchini, J Jaeken.   

Abstract

Carbohydrate-deficient glycoconjugate (CDG) syndrome type I due to phosphomannomutase deficiency (CDGIA) is the most common among a group of metabolic disorders characterized by a defective glycosylation of glycoconjugates. Clinically it is a multisystem disease with an important involvement of the central nervous system including pontocerebellar atrophy. Here the developmental patterns and results of neuropsychological assessment of four young adults with CDGIA syndrome are reported. The patients, aged 14-26 years, had classical clinical findings of CDGIA syndrome and olivopontocerebellar atrophy of severe degree. They had a marked delay in all areas of psychomotor development and gained to walk with aid, perform manipulative abilities and develop a communicative language after the 7th year. Later on, the acquired abilities remained stable, while self-help skills gradually improved, allowing the patients to join the family life. On neuropsychological assessment, there was mental retardation of variable degree with a special impairment of visuoperceptual skills, visuospatial organization, eye-hand coordination, verbal memory and language. Such findings, may be partially explained by the supratentorial atrophy in our patients and add more evidences to the role of the cerebellum and brainstem in the acquisition of non-motor cognitive functions. This study expands our understanding on the clinical spectrum of CDGIA syndrome and may be helpful for planning rehabilitation and education.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10392749     DOI: 10.1016/s0387-7604(99)00020-0

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  8 in total

Review 1.  New disorders in carbohydrate metabolism: congenital disorders of glycosylation and their impact on the endocrine system.

Authors:  Bradley S Miller; Hudson H Freeze
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

2.  Mapping of spinocerebellar ataxia 13 to chromosome 19q13.3-q13.4 in a family with autosomal dominant cerebellar ataxia and mental retardation.

Authors:  A Herman-Bert; G Stevanin; J C Netter; O Rascol; D Brassat; P Calvas; A Camuzat; Q Yuan; M Schalling; A Dürr; A Brice
Journal:  Am J Hum Genet       Date:  2000-05-11       Impact factor: 11.025

3.  High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency).

Authors:  S Grünewald; E Schollen; E Van Schaftingen; J Jaeken; G Matthijs
Journal:  Am J Hum Genet       Date:  2001-01-11       Impact factor: 11.025

Review 4.  Carbohydrate-deficient glycoprotein syndromes.

Authors:  N Gordon
Journal:  Postgrad Med J       Date:  2000-03       Impact factor: 2.401

5.  Congenital disorder of glycosylation type Ia (CDG-Ia): phenotypic spectrum of the R141H/F119L genotype.

Authors:  S Kjaergaard; M Schwartz; F Skovby
Journal:  Arch Dis Child       Date:  2001-09       Impact factor: 3.791

6.  The normal phenotype of Pmm1-deficient mice suggests that Pmm1 is not essential for normal mouse development.

Authors:  K Cromphout; W Vleugels; L Heykants; E Schollen; L Keldermans; R Sciot; R D'Hooge; P P De Deyn; K von Figura; D Hartmann; C Körner; G Matthijs
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

7.  Congenital disorder of glycosylation type Ia: heterogeneity in the clinical presentation from multivisceral failure to hyperinsulinaemic hypoglycaemia as leading symptoms in three infants with phosphomannomutase deficiency.

Authors:  B Shanti; M Silink; K Bhattacharya; N J Howard; K Carpenter; M Fietz; P Clayton; J Christodoulou
Journal:  J Inherit Metab Dis       Date:  2009-04-27       Impact factor: 4.982

8.  Distinct Glycosylation Responses to Spinal Cord Injury in Regenerative and Nonregenerative Models.

Authors:  Rachel Ronan; Aniket Kshirsagar; Ana Lúcia Rebelo; Abbah Sunny; Michelle Kilcoyne; Roisin O' Flaherty; Pauline M Rudd; Gerhard Schlosser; Radka Saldova; Abhay Pandit; Siobhan S McMahon
Journal:  J Proteome Res       Date:  2022-05-04       Impact factor: 5.370

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.